Article
Clinical phenotyping uncovers heterogeneous associations between corticosteroid treatment and survival in critically ill COVID-19 patients.
Intensive care medicine - 1 Nov 2024
Bruse Niklas, Motos Anna, van Amstel Rombout, de Bie Eckart, Kooistra Emma J, Jansen Aron, van Lier Dirk, Kennedy Jason, Schwarzkopf Daniel, Thomas-Rüddel Daniel, Bermejo-Martin Jesus F, Barbe Ferran, de Keizer Nicolette F, Bauer Michael, van der Hoeven Johannes G, Torres Antoni, Seymour Christopher, van Vught Lonneke, Pickkers Peter, Kox Matthijs
Abstract excerpt
PURPOSE: Disease heterogeneity in coronavirus disease 2019 (COVID-19) may render the current one-size-fits-all treatment approach suboptimal. We aimed to identify and immunologically characterize clinical phenotypes among critically ill COVID-19 patients, and to assess heterogeneity of corticosteroid treatment effect. METHODS: We applied consensus k-means clustering on 21 clinical parameters obtained within 24 h...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
